Skip to main content
OpenTrials

Clinical trial condition

Pharyngeal Neoplasms

Explore clinical trials studying Pharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

734 public trials 231 recruiting studies
Refine in advanced search Browse all conditions

Pharyngeal Neoplasms trial results

Completed

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

NCT02269943

Conditions
Carcinoma, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia Comprehensive Cancer Care Clinic Jefferson City, Missouri, United States
View all 25 locations
View Trial Details
Completed

Early Use of Opioid in Radiation Mucositis

NCT02309437

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +18 more
Locations
  • Cancer Center Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Guangzhou Panyu Center Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • People's Hospital of Boluo County Huizhou, Guangdong, China
View Trial Details
Completed

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

NCT01800071

Conditions
DNA Virus Infections, Epstein Barr Virus Infections, Epstein-Barr Virus Infections, +15 more
Locations
  • University of Birmingham Edgbaston, Birmingham, United Kingdom
  • Royal Marsden Hospital Fulham Road, London, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
  • The Beatson West of Scotland Cancer Glasgow, United Kingdom
View Trial Details
Completed

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

NCT00052611

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +18 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions